HELX
Franklin Genomic Advancements ETF · BATS
- Category Equity
- Expense Ratio 0.5%
- Listing Date Feb 27, 2020
- Volume 1,629.0
- Market Cap (AUM) $9.37M
Performance
+3.93%
1W
-2.46%
1M
+2.66%
3M
+15.91%
6M
+2.54%
YTD
+3.73%
1Y
Top Holdings
-
Name
Symbol%Assets
- Medpace Holdings, Inc.MEDP7.81%
- Thermo Fisher Scientific Inc.TMO4.92%
- Vertex Pharmaceuticals IncorporatedVRTX4.76%
- Regeneron Pharmaceuticals, Inc.REGN4.53%
- Eli Lilly and CompanyLLY4.42%
- Danaher CorporationDHR4.16%
- Krystal Biotech, Inc.KRYS4.03%
- Bruker CorporationBRKR3.08%
- Natera, Inc.NTRA3.07%
- SAMSUNG BIOLOGICS Co., Ltd.2079403.01%
Technical Analysis of HELX 2024-05-03
Overview:
In analyzing the technical indicators for HELX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around the c...
Recent News & Updates
- 2021-07-15 23:19
- 2021-01-13 20:15
Franklin Adds To Thematic ETF Line(Yahoo Finance)
- 2020-10-04 20:00
Page 1 of 1
previousnext